Wolverine Trading, LLC Geron Corp Call Options Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$1.75 - $3.44 $12,425 - $24,424	-7,100 Reduced 6.4%	103,800 $342,000
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $17,400 - $23,100	10,000 Added 9.91%	110,900 $233,000
Q3 2023 Nov 15, 2023	BUY	$2.11 - $3.28 $38,191 - $59,368	18,100 Added 21.86%	100,900 $213,000
Q2 2023 Aug 23, 2023	BUY	$1.97 - $3.69 $6,304 - $11,808	3,200 Added 4.02%	82,800 $265,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $170,344 - $270,640	79,600 New	79,600 $170,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $74,649 - $131,418	44,700 Added 101.13%	88,900 $205,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $8,806 - $12,210	7,400 Added 20.11%	44,200 $67,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $2,772 - $4,480	-2,800 Reduced 7.07%	36,800 $59,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $9,150 - $12,900	-7,500 Reduced 15.92%	39,600 $50,000
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $43,800 - $54,750	-36,500 Reduced 43.66%	47,100 $65,000
Q2 2021 Aug 06, 2021	BUY	$1.25 - $1.83 $39,250 - $57,462	31,400 Added 60.15%	83,600 $117,000
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $55,024 - $76,020	36,200 Added 226.25%	52,200 $79,000
Q4 2020 Feb 12, 2021	SELL	$1.55 - $2.05 $22,010 - $29,109	-14,200 Reduced 47.02%	16,000 $25,000
Q3 2020 Nov 13, 2020	SELL	$1.59 - $2.19 $4,611 - $6,351	-2,900 Reduced 8.76%	30,200 $53,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $12,915 - $26,814	12,300 Added 59.13%	33,100 $70,000
Q1 2020 May 11, 2020	SELL	$0.89 - $1.49 $32,930 - $55,130	-37,000 Reduced 64.01%	20,800 $24,000
Q4 2019 Feb 12, 2020	BUY	$1.27 - $1.54 $15,621 - $18,942	12,300 Added 27.03%	57,800 $78,000
Q3 2019 Nov 14, 2019	BUY	$1.15 - $1.59 $4,255 - $5,883	3,700 Added 8.85%	45,500 $61,000
Q2 2019 Aug 20, 2019	BUY	$1.37 - $2.02 $8,905 - $13,130	6,500 Added 18.41%	41,800 $59,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $57,166 - $103,578	-56,600 Reduced 61.59%	35,300 $59,000
Q4 2018 Feb 14, 2019	SELL	$0.98 - $1.85 $267,834 - $505,605	-273,300 Reduced 74.84%	91,900 $94,000
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $220,000 - $797,500	125,000 Added 52.04%	365,200 $643,000
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $413,223 - $1.37 Million	228,300 Added 1918.49%	240,200 $1.02 Million
Q4 2017 Feb 14, 2018	SELL	$1.8 - $2.32 $92,880 - $119,711	-51,600 Reduced 81.26%	11,900 $21,000
Q3 2017 Nov 15, 2017	BUY	$1.99 - $2.65 $126,365 - $168,275	63,500	63,500 $138,000

Others Institutions Holding GERN

# of Institutions

259

Shares Held

450M

Call Options Held

1.91M

Put Options Held

897K

Black Rock Inc. New York, NY

46.6M
Shares

$196 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

46.2M
Shares

$195 Million
2.95% of portfolio
Vanguard Group Inc Valley Forge, PA

31.9M
Shares

$135 Million
0.0% of portfolio
Vivo Capital, LLC Palo Alto, CA

27.2M
Shares

$115 Million
17.06% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

23.9M
Shares

$101 Million
12.26% of portfolio

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account